{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "marketState": "PREPRE", "regularMarketChangePercent": 0.23310024, "regularMarketPrice": 21500.0, "exchange": "KSC", "shortName": "HANALL BIOPHARMA", "longName": "Hanall Biopharma Co., Ltd.", "messageBoardId": "finmb_9284368", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketTime": 1683873028, "earningsTimestamp": 1682679613, "earningsTimestampStart": 1690282740, "earningsTimestampEnd": 1690804800, "epsCurrentYear": 163.23, "priceEpsCurrentYear": 131.71599, "sharesOutstanding": 50690400, "fiftyDayAverage": 19632.2, "fiftyDayAverageChange": 1867.8008, "fiftyDayAverageChangePercent": 0.09513966, "twoHundredDayAverage": 16575.45, "twoHundredDayAverageChange": 4924.551, "twoHundredDayAverageChangePercent": 0.29709908, "marketCap": 1089843625984, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "prevName": "Hanall Biopharma Co.,Ltd", "nameChangeDate": "2023-05-13", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 946944000000, "priceHint": 2, "regularMarketChange": 50.0, "regularMarketDayHigh": 21650.0, "regularMarketDayRange": "21000.0 - 21650.0", "regularMarketDayLow": 21000.0, "regularMarketVolume": 304580, "regularMarketPreviousClose": 21450.0, "bid": 21450.0, "ask": 21500.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KSE", "financialCurrency": "KRW", "regularMarketOpen": 21250.0, "averageDailyVolume3Month": 457564, "averageDailyVolume10Day": 371613, "fiftyTwoWeekLowChange": 9050.0, "fiftyTwoWeekLowChangePercent": 0.7269076, "fiftyTwoWeekRange": "12450.0 - 23800.0", "fiftyTwoWeekHighChange": -2300.0, "fiftyTwoWeekHighChangePercent": -0.09663866, "fiftyTwoWeekLow": 12450.0, "fiftyTwoWeekHigh": 23800.0, "symbol": "009420.KS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Daewoong Building", "address2": "9th Floor 12 Bongeunsaro 114-gil Gangnam-gu", "city": "Seoul", "country": "South Korea", "website": "https://www.hanall.co.kr", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Sean  Jeong", "title": "Pres, Co-CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Su-Jin  Park", "title": "Co-CEO, VP & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Nam-Yong  Cho", "age": 68, "title": "Sr. Exec. Director of Sales & Marketing and Sr. Managing Director", "yearBorn": 1954, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}